Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications

被引:49
|
作者
Schoen, Christian [1 ]
Biel, Martin [1 ]
Michalakis, Stylianos [1 ]
机构
[1] Univ Munich, Ctr Drug Res, Dept Pharm, Ctr Integrated Prot Sci Munich CiPSM, D-81377 Munich, Germany
关键词
Adeno-associated virus; Retina; Gene therapy; AAV capsid; AAV genome; Subretinal injection; Intravitreal injection; LEBER CONGENITAL AMAUROSIS; RESTORES VISUAL RESPONSES; HIGH-EFFICIENCY TRANSDUCTION; GROWTH-FACTOR RECEPTOR; CELL-TYPE SPECIFICITY; TRANSGENIC RAT MODEL; EXPRESSION IN-VIVO; LONG-TERM; MOUSE MODEL; VIRAL VECTOR;
D O I
10.1016/j.ejpb.2015.01.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adeno-associated virus (AAV) vectors are the most widely used vehicle systems for neuronal gene transfer. This popularity is based on the non-pathogenic nature of AAVs and their versatility making them a multifunctional vector system for basic research and clinical applications. AAVs are successfully applied in clinical and pre-clinical gene therapy studies for inherited retinal disorders. Their excellent transduction profile and efficiency also boosted the use of AAV vectors in basic research, The AAV vector system can be easily modified and adjusted at multiple levels to allow for optimized and specific gene expression in target cells. Here, we will provide an overview on the AAV vector system and its applications focusing on gene transfer into retinal cells. Furthermore, we will outline and discuss strategies for the optimization of AAV gene transfer by modifications to the AAV vector expression cassette, the AAV capsid or the routes of vector administration. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:343 / 352
页数:10
相关论文
共 50 条
  • [1] Adeno-associated virus (AAV) vectors in gene therapy
    Serra, C
    Zentilin, L
    Tafuro, S
    Falaschi, A
    Giacca, M
    [J]. MINERVA BIOTECNOLOGICA, 1997, 9 (03) : 155 - 165
  • [2] Adeno-associated virus (AAV) vectors in cancer gene therapy
    Santiago-Ortiz, Jorge L.
    Schaffer, David V.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2016, 240 : 287 - 301
  • [3] Adeno-associated virus (AAV) vectors in the CNS
    McCown, TJ
    [J]. CURRENT GENE THERAPY, 2005, 5 (03) : 333 - 338
  • [4] Adeno-associated virus vectors vascular gene delivery
    Lynch, CM
    Hara, PS
    Leonard, JC
    Williams, JK
    Dean, RH
    Geary, RL
    [J]. CIRCULATION RESEARCH, 1997, 80 (04) : 497 - 505
  • [5] Adeno-Associated Virus (AAV) Vectors in the CNS
    McCown, Thomas J.
    [J]. CURRENT GENE THERAPY, 2011, 11 (03) : 181 - 188
  • [6] Integration of adeno-associated virus (AAV) and recombinant AAV vectors
    McCarty, DM
    Young, SM
    Samulski, RJ
    [J]. ANNUAL REVIEW OF GENETICS, 2004, 38 : 819 - 845
  • [7] Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
    Arjomandnejad, Motahareh
    Dasgupta, Ishani
    Flotte, Terence R.
    Keeler, Allison M.
    [J]. BIODRUGS, 2023, 37 (03) : 311 - 329
  • [8] Strategies for gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors
    Ozawa, K
    Fan, D
    Ogawa, M
    Urabe, M
    Kume, A
    Monahan, J
    Nakano, I
    [J]. BIOGENIC AMINES, 1999, 15 (01) : 21 - 37
  • [9] Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
    Motahareh Arjomandnejad
    Ishani Dasgupta
    Terence R. Flotte
    Allison M. Keeler
    [J]. BioDrugs, 2023, 37 : 311 - 329
  • [10] Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them
    Hareendran, Sangeetha
    Balakrishnan, Balaji
    Sen, Dwaipayan
    Kumar, Sanjay
    Srivastava, Alok
    Jayandharan, Giridhara R.
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2013, 23 (06) : 399 - 413